Taylor Wessing advised Oxford Cancer Analytics Ltd (OXcan) on the deal. Marriott Harrison advised We Venture Capital and Cross-Border Impact Ventures.Oxford Cancer Analytics Ltd (OXcan) completed…
Oxford Cancer Analytics’ $11 Million Series A Investment Round
